Skip to main content

Oncology

Oncology Overview, Oncology

NCCN Guidelines Update: Initial Colorectal Screening Lowered to Age 45

Disparities in Cancer Care, Conference Highlights ASCO, Oncology

ASCO 2021 Presidential Address: Eliminating Disparities in Cancer Care

Wayne Kuznar

Conference Highlights ASCO, Lung Cancer, Oncology

Atezolizumab Extends Disease-Free Survival in PD-L1−Positive Early-Stage NSCLC

Phoebe Starr

Multiple Myeloma, Conference Highlights ASCO, Oncology

New CAR T-Cell Therapy Produces Durable Responses in Relapsed or Refractory Multiple Myeloma

Wayne Kuznar

FDA Approvals, Leukemia, Lymphoma, Conference Highlights ASCO, Oncology

Rylaze FDA Approved as Part of a Treatment Regimen for Pediatric Leukemia and Lymphoma

Cholangiocarcinoma, FDA Approvals, Conference Highlights ASCO, Oncology

Truseltiq Second Targeted Therapy Approved for Metastatic Cholangiocarcinoma Harboring FGFR2 Alterations

FDA Approvals, Multiple Myeloma, Conference Highlights ASCO, Oncology

FDA Approves Darzalex Faspro plus Pomalyst and Dexamethasone for Multiple Myeloma

FDA Approvals, Urothelial Cancer, Conference Highlights ASCO, Oncology

Padcev Receives Regular FDA Approval for Locally Advanced or Metastatic Urothelial Cancer

Melanoma, Conference Highlights ASCO, Oncology

Novel LAG-3–Blocking Antibody plus Nivolumab Shows Promise as First-Line Treatment in Advanced Melanoma

Wayne Kuznar

Renal-Cell Carcinoma, Conference Highlights ASCO, Oncology

Adjuvant Pembrolizumab Therapy Significantly Extends Disease-Free Survival in Patients with Clear-Cell Renal-Cell Carcinoma

Phoebe Starr

Page 2 of 27
Results 11 - 20 of 262